GC Aesthetics appoints Luigi Ferrari to its Board of Directors as Non-Executive Chairman alongside Patrick Lee joining as Board Director

– IRELAND, Dublin –  GC Aesthetics, a privately-held medical technology company providing aesthetic and reconstruction solutions for global healthcare markets, announced the appointments of Luigi Ferrari as non-executive Chairman of its Board of Directors and of Patrick Lee as a Board Director, reinforcing the strategic direction and long-term growth plans.

About Luigi Ferrari,

Luigi Ferrari is a seasoned executive and investor with a proven track record in the healthcare sector. He brings deep leadership experience, commercial growth expertise, and industry insight. From 2012 to 202,2, he was CEO of Lima Corporate, a global medical device company in the joint replacement market, acquired then by Enovis Corporation. Previous working experience includes several roles within Orthofix, the last one as President t Global Orthopedics.

Luigi Ferrari holds a M.Sc. in Management Engineering from the Polytechnic of Milan and completed the Advanced Management Program at the Harvard Business School.

About Patrick Lee

Patrick Lee brings a strong background in building and scaling successful businesses internationally. Over the last three decades, he has held senior roles at Advent Venture Partners and Ares Life Sciences, investment funds specializing in healthcare, and at global pharma companies.

Patrick Lee holds a B. A graduate from Vassar College and an MBA from the Stanford Graduate School of Business. His broad experience and perspective will further enhance GCA’s ability to deliver on its global ambitions.

About GC Aesthetics

GC Aesthetics is a long-established global medical technology company that develops, manufactures, and markets a comprehensive range of proprietary aesthetic and reconstructive products.

Throughout its 40-year history, GCA has been dedicated to advancing the science of medical aesthetics and delivering high-quality breast implants for breast augmentation and breast reconstructive surgery. We have sold more than 3 million implants across 70 countries, and our products are supported by published 10-year clinical data.

For more: https://www.gcaesthetics.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.